Privately funded clinical trials bring with them added complexities, with securing ongoing investment often dependent on the research organisation’s ability to meet a series of ambitious key performance indicators, within short, inflexible timeframes.

For one pharmaceutical company, responding to investor demands to drastically shorten drug delivery timeframes by 25%, meant unifying IRT and Clinical Supplies processes with speed and precision to secure vital funding, optimise operations and save time.

Download our case study to find out how Almac’s One Clinical Trial Supply Solution helped the sponsor to respond with speed and accuracy to its investor’s demands and meet its study milestones.